Ammonium molybdate

DB11128InvestigationalSmall molecule

Ammonium molybdate is a source of molybdenum that exists in several hydrate forms. It is intravenously administered as an additive to solutions for Total Parenteral Nutrition (TPN). Molybdenum is an... Molybdenum is an essential element that is present in enzymes including xanthine oxidase, sulfite oxidase, and aldehyde oxidase.

Formula / weight: H₃₂Mo₇N₆O₂₈ · 1235.92 g/mol (avg)
Also known as: Ammonium molybdate tetrahydrate · Ammonium molybdate(VI) tetrahydrate · Ammonium paramolybdate tetrahydrate · Hexaammonium heptamolybdate tetrahydrate · Hexaammonium molybdate tetrahydrate

Resolves to

Compound

UNIIOGI154X474CAS12054-85-2PubChem485454

Clinical / RWD

RxNorm17789

Structure

InChIKeyFZDJSHPVOMNEIF-UHFFFAOYSA-TSMILES

[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].O.O.O.O.[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mo+6].[Mo+6].[Mo+6].[Mo+6].[Mo+6].[Mo+6].[Mo+6]

Targets

P08842STS

What you can answer from here — as of July 06, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3Structured indicationsCondition, population, route and combination as fields, not prose

1Marketed productAcross 1 country and 1 labeller

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Ammonium molybdate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account